Clinical Trial Update: Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating CAR-T cell therapy for HIV-infected individuals with AIDS-related and other B-cell non-Hodgkin lymphomas; currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aids-related Diffuse Large B-cell Lymphoma
• Aids-related Non-hodgkin Lymphoma
• Diffuse Large B-cell Lymphoma
• Grade 3b Follicular Lymphoma
• HIV Infection
• Mediastinal Large B-cell Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• CAR T cell therapy (investigational) (chimeric antigen receptor T cell therapy)

Snippet

Sponsor: AIDS Malignancy Consortium | Conditions: AIDS-Related Diffuse Large B-cell Lymphoma, AIDS-Related Non-Hodgkin Lymphoma | Phase 1 | Status: RECRUITING